Abiopharma

🔍 Greenberg David C. (Director)

Company: ICU MEDICAL INC/DE (ICUI)

Report Date: 2025-08-27

Detailed Transactions and Holdings:

• Acquired 602 shares of Common Stock at $126.1428 per share (Direct)
  Date: 2025-08-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 7,362.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 598 shares of Common Stock at $126.6895 per share (Direct)
  Date: 2025-08-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 7,960.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 500.00

Footnotes:

• F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $125.52 to $126.48, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
• F2: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $126.55 to $127.14, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.